Eur J Endocrinol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


DOI: 10.1530/eje.1.02249
European Journal of Endocrinology, Vol 155, Issue 4, 615-622
Copyright © 2006 by European Society of Endocrinology
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (2)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shim, W. S.
Right arrow Articles by Cha, B. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shim, W. S.
Right arrow Articles by Cha, B. S.

CLINICAL STUDY

Decrement of postprandial insulin secretion determines the progressive nature of type-2 diabetes

Wan Sub Shim, Soo Kyung Kim3, Hae Jin Kim4, Eun Seok Kang2, Chul Woo Ahn1,2, Sung Kil Lim1,2, Hyun Chul Lee1,2 and Bong Soo Cha1,2

Department of Internal Medicine, Inha University College of Medicine, Incheon, Korea, 1 Brain Korea 21, Project for Medical Science and 2 Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea, 3 Department of Internal Medicine, College of Medicine, Pochon CHA University, Sungnam, Kyunggi-do, Korea and 4 Department of Endocrinology and Metabolism, Ajou University School of Medicine, Suwon, Korea

(Correspondence should be addressed to B S Cha; Email: bscha{at}yumc.yonsei.ac.kr)

Objective: Type-2 diabetes is a progressive disease. However, little is known about whether decreased fasting or postprandial pancreatic ß-cell responsiveness is more prominent with increased duration of diabetes. The aim of this study was to evaluate the relationship between insulin secretion both during fasting and 2 h postprandial, and the duration of diabetes in type-2 diabetic patients.

Design: Cross-sectional clinical investigation.

Methods: We conducted a meal tolerance test in 1466 type-2 diabetic patients and calculated fasting (M0) and postprandial (M1) ß-cell responsiveness.

Results: The fasting C-peptide, postprandial C-peptide, M0, and M1 values were lower, but HbA1c values were higher, in patients with diabetes duration > 10 years than those in other groups. There was no difference in the HbA1c levels according to the tertiles of their fasting C-peptide level. However, in a group of patients with highest postprandial C-peptide tertile, the HbA1c values were significantly lower than those in other groups. After adjustment of age, sex, and body mass index (BMI), the duration of diabetes was found to be negatively correlated with fasting C-peptide ({gamma} = –0.102), postprandial C-peptide ({gamma} = –0.356), M0 ({gamma} = –0.263), and M1 ({gamma} = –0.315; P < 0.01 respectively). After adjustment of age, sex, and BMI, HbA1c was found to be negatively correlated with postprandial C-peptide ({gamma} = –0.264), M0 ({gamma} = –0.379), and M1 ({gamma} = –0.522), however, positively correlated with fasting C-peptide ({gamma} = 0.105; P < 0.01 respectively). In stepwise multiple regression analysis, M0, M1, and homeostasis model assessment for insulin resistance (HOMA-IR) emerged as predictors of HbAlc after adjustment for age, sex, and BMI (R2 = 0.272, 0.080, and 0.056 respectively).

Conclusions: With increasing duration of diabetes, the decrease of postprandial insulin secretion is becoming more prominent, and postprandial ß-cell responsiveness may be a more important determinant for glycemic control than fasting ß-cell responsiveness.




This article has been cited by other articles:


Home page
Eur J EndocrinolHome page
C. D Dieterle, H. Arbogast, W.-D. Illner, S. Schmauss, and R. Landgraf
Metabolic follow-up after long-term pancreas graft survival
Eur. J. Endocrinol., May 1, 2007; 156(5): 603 - 610.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 European Society of Endocrinology.